loading…
J2502 Injection, pasireotide long acting, 1 mg
BackJ2002Injection, lidocaine hcl in 5% dextrose, 1 mg→J2003Injection, lidocaine hydrochloride, 1 mg→J2004Injection, lidocaine hcl with epinephrine, 1 mg→J2010Injection, lincomycin hcl, up to 300 mg→J2020Injection, linezolid, 200 mg→J2021Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg→J2060Injection, lorazepam, 2 mg→J2062Loxapine for inhalation, 1 mg→J2151Injection, mannitol, 250 mg→J2170Injection, mecasermin, 1 mg→J2175Injection, meperidine hydrochloride, per 100 mg→J2180Injection, meperidine and promethazine hcl, up to 50 mg→J2182Injection, mepolizumab, 1 mg→J2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg→J2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg→J2185Injection, meropenem, 100 mg→J2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)→J2210Injection, methylergonovine maleate, up to 0.2 mg→J2212Injection, methylnaltrexone, 0.1 mg→J2246Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg→J2247Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg→J2248Injection, micafungin sodium, 1 mg→J2249Injection, remimazolam, 1 mg→J2250Injection, midazolam hydrochloride, per 1 mg→J2251Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg→J2252Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg→J2253Injection, midazolam (seizalam), 1 mg→J2260Injection, milrinone lactate, 5 mg→J2265Injection, minocycline hydrochloride, 1 mg→J2267Injection, mirikizumab-mrkz, 1 mg→J2270Injection, morphine sulfate, up to 10 mg→J2272Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg→J2274Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg→J2277Injection, motixafortide, 0.25 mg→J2278Injection, ziconotide, 1 microgram→J2280Injection, moxifloxacin, 100 mg→J2281Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg→J2290Injection, nafcillin sodium, 20 mg→J2291Injection, nafcillin sodium (baxter), 20 mg→J2300Injection, nalbuphine hydrochloride, per 10 mg→J2305Injection, nitroglycerin, 5 mg→J2312Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg→J2313Injection, naloxone hydrochloride (zimhi), 0.01 mg→J2315Injection, naltrexone, depot form, 1 mg→J2320Injection, nandrolone decanoate, up to 50 mg→J2323Injection, natalizumab, 1 mg→J2325Injection, nesiritide, 0.1 mg→J2326Injection, nusinersen, 0.1 mg→J2327Injection, risankizumab-rzaa, intravenous, 1 mg→J2329Injection, ublituximab-xiiy, 1mg→J2350Injection, ocrelizumab, 1 mg→J2351Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq→J2353Injection, octreotide, depot form for intramuscular injection, 1 mg→J2354Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg→J2355Injection, oprelvekin, 5 mg→J2356Injection, tezepelumab-ekko, 1 mg→J2357Injection, omalizumab, 5 mg→J2358Injection, olanzapine, long-acting, 1 mg→J2359Injection, olanzapine, 0.5 mg→J2360Injection, orphenadrine citrate, up to 60 mg→J2361Injection, depemokimab-ulaa, 1 mg→J2371Injection, phenylephrine hydrochloride, 20 micrograms→J2372Injection, phenylephrine hydrochloride (biorphen), 20 micrograms→J2373Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms→J2374Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml→J2401Injection, chloroprocaine hydrochloride, per 1 mg→J2402Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg→J2403Chloroprocaine hcl ophthalmic, 3% gel, 1 mg→J2404Injection, nicardipine, 0.1 mg→J2405Injection, ondansetron hydrochloride, per 1 mg→J2406Injection, oritavancin (kimyrsa), 10 mg→J2407Injection, oritavancin (orbactiv), 10 mg→J2410Injection, oxymorphone hcl, up to 1 mg→J2425Injection, palifermin, 50 micrograms→J2426Injection, paliperidone palmitate extended release (invega sustenna), 1 mg→J2427Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg→J2428Injection, paliperidone palmitate extended release (erzofri), 1 mg→J2430Injection, pamidronate disodium, per 30 mg→J2440Injection, papaverine hcl, up to 60 mg→J2460Injection, oxytetracycline hcl, up to 50 mg→J2468Injection, palonosetron hydrochloride (posfrea), 25 micrograms→J2469Injection, palonosetron hcl, 25 mcg→J2470Injection, pantoprazole sodium, 40 mg→J2471Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg→J2472Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg→J2501Injection, paricalcitol, 1 mcg→J2502Injection, pasireotide long acting, 1 mg→J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg→J2507Injection, pegloticase, 1 mg→J2508Injection, pegunigalsidase alfa-iwxj, 1 mg→J2510Injection, penicillin g procaine, aqueous, up to 600,000 units→J2515Injection, pentobarbital sodium, per 50 mg→J2516Injection, pentamidine isethionate, 1 mg→J2540Injection, penicillin g potassium, up to 600,000 units→J2543Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)→J2545Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg→J2547Injection, peramivir, 1 mg→J2550Injection, promethazine hcl, up to 50 mg→J2560Injection, phenobarbital sodium, up to 120 mg→J2561Injection, phenobarbital sodium (sezaby), 1 mg→J2562Injection, plerixafor, 1 mg→J2590Injection, oxytocin, up to 10 units→J2596Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit→J2597Injection, desmopressin acetate, per 1 mcg→J2598Injection, vasopressin, 1 unit→J2599Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit→J2601Injection, vasopressin (baxter), 1 unit→J2650Injection, prednisolone acetate, up to 1 ml→J2670Injection, tolazoline hcl, up to 25 mg→J2675Injection, progesterone, per 50 mg→J2679Injection, fluphenazine hcl, 1.25 mg→J2680Injection, fluphenazine decanoate, up to 25 mg→J2690Injection, procainamide hcl, up to 1 gm→J2700Injection, oxacillin sodium, up to 250 mg→J2704Injection, propofol, 10 mg→J2710Injection, neostigmine methylsulfate, up to 0.5 mg→J2711Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg→J2720Injection, protamine sulfate, per 10 mg→J2724Injection, protein c concentrate, intravenous, human, 10 iu→J2725Injection, protirelin, per 250 mcg→J2730Injection, pralidoxime chloride, up to 1 gm→J2760Injection, phentolamine mesylate, up to 5 mg→J2765Injection, metoclopramide hcl, up to 10 mg→J2770Injection, quinupristin/dalfopristin, 500 mg (150/350)→J2777Injection, faricimab-svoa, 0.1 mg→J2778Injection, ranibizumab, 0.1 mg→J2779Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg→J2781Injection, pegcetacoplan, intravitreal, 1 mg→J2782Injection, avacincaptad pegol, 0.1 mg→J2783Injection, rasburicase, 0.5 mg→J2785Injection, regadenoson, 0.1 mg→J2786Injection, reslizumab, 1 mg→J2787Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml→J2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)→J2789Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml→J2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)→J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu→J2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu→J2793Injection, rilonacept, 1 mg→J2794Injection, risperidone (risperdal consta), 0.5 mg→J2795Injection, ropivacaine hydrochloride, 1 mg→J2797Injection, rolapitant, 0.5 mg→J2798Injection, risperidone, (perseris), 0.5 mg→J2799Injection, risperidone (uzedy), 1 mg→J2800Injection, methocarbamol, up to 10 ml→J2801Injection, risperidone (rykindo), 0.5 mg→J2802Injection, romiplostim, 1 microgram→J2804Injection, rifampin, 1 mg→J2805Injection, sincalide, 5 micrograms→J2810Injection, theophylline, per 40 mg→J2820Injection, sargramostim (gm-csf), 50 mcg→J2840Injection, sebelipase alfa, 1 mg→J2850Injection, secretin, synthetic, human, 1 microgram→J2860Injection, siltuximab, 10 mg→J2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg→J2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg→J2919Injection, methylprednisolone sodium succinate, 5 mg→J2941Injection, somatropin, 1 mg→J2950Injection, promazine hcl, up to 25 mg→J2993Injection, reteplase, 18.1 mg→J2997Injection, alteplase recombinant, 1 mg→J2998Injection, plasminogen, human-tvmh, 1 mg→
Procedure codeCODABLE
J2502
Injection, pasireotide long acting, 1 mg
- Part
- HCPCS Level II
- J
- Drugs Administered Other than Oral Method
- J2
- J2002–J2998
Source
CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.